Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema
Status:
Withdrawn
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of the 20 mL BLVR System in
treating patients with advanced upper lobe predominant emphysema.